Markets:

Overview

News

Currencies

International

Treasuries

Opko Health, Inc. - Common Stock (NQ:OPK)

1.180 +0.010 (+0.85%)

Streaming Delayed Price Updated: 4:00 PM EST, Mar 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Opko Health, Inc. - Common Stock

Market Brief: After Viking Therapeutics’ Results, Is Entera Bio the Oral Platform Play to Watch? (NASDAQ: ENTX)

August 22, 2025

Via AB Newswire

TechMediaBreaks – NextPlat Corp (NASDAQ: NXPL) Announces ‘Significant’ Extension and Expansion of Exclusive Distribution Agreement with OPKO Health

October 07, 2024

Via Investor Brand Network

TechMediaBreaks – NextPlat Corp (NASDAQ: NXPL) Expands E-Commerce Program in China

July 02, 2024

Via Investor Brand Network

2 penny stocks insiders are buying

February 27, 2024

Penny stocks come with outsized risks, but some risks can be mitigated by following the insiders. Insiders aren't going to waste good money on a bad company.

Via MarketBeat

These are the 4 hottest stocks insiders bought in January

January 29, 2024

Insiders are buying these stocks, but not all are good buys for investors or bullish traders; avoid stocks with high short interest, no revenue, and no earnings

Via MarketBeat

NextPlat latest financial numbers shows double-digit growth in e-commerce and healthcare division

November 15, 2023

Charlie Fernandez, CEO of NextPlat, provided an update on the company's latest financial results during an interview with Steve Darling from Proactive.

Via TheNewswire.com

BioMedNewsBreaks – NextPlat Corp. (NASDAQ: NXPL) Announces Launch of OPKO Health Inc. (NASDAQ: OPK)-Branded Online Storefront

October 12, 2023

Via Investor Brand Network

NextPlat's Florida E-Commerce Development Program to Launch the Online Sales of OPKO Healthcare Products in China on Alibaba's Tmall Global

October 12, 2023

Via ACCESSWIRE

MarketBeat Week in Review – 7/17 - 7/21

July 22, 2023

Investor sentiment remains strong but upcoming tech earnings and an expected interest rate hike may provide more clarity on the short-term outlook for stocks

Via MarketBeat

Topics Economy

OPKO Health is the Little Giant of Diversified Healthcare

July 19, 2023

Diversified healthcare company OPKO Health Inc. (NASDAQ: OPK) shares may be low priced, but its businesses pipeline of treatments and upside potential may

Via MarketBeat

Topics Intellectual Property

FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency

June 28, 2023

From Pfizer Inc.

Via Business Wire

Rising Incidence of Pancreatic Cancer Driving Demand for Advanced Treatment Therapies

November 07, 2022

Palm Beach, FL – November 7, 2022 – FinancialNewsMedia.com News Commentary – While there is no cure for pancreatic cancer in the pancreatic cancer treatment market, new treatment options abound, and...

Via FinancialNewsMedia

Pfizer and OPKO’s Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency

February 15, 2022

From Pfizer Inc.

Via Business Wire

Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency

January 21, 2022

From Pfizer Inc.

Via Business Wire

OPKO Health to Participate in the 40th Annual J.P. Morgan Healthcare Conference

January 05, 2022

From OPKO Health, Inc.

Via Business Wire

Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School’ COVID-19 Testing Program

August 26, 2021

From Rite Aid Corporation

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.